These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25700349)

  • 1. T lymphocyte-derived TNF and IFN-γ repress HFE expression in cancer cells.
    Reuben A; Godin-Ethier J; Santos MM; Lapointe R
    Mol Immunol; 2015 Jun; 65(2):259-66. PubMed ID: 25700349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The WT hemochromatosis protein HFE inhibits CD8⁺ T-lymphocyte activation.
    Reuben A; Phénix M; Santos MM; Lapointe R
    Eur J Immunol; 2014 Jun; 44(6):1604-14. PubMed ID: 24643698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity.
    Donia M; Andersen R; Kjeldsen JW; Fagone P; Munir S; Nicoletti F; Andersen MH; Thor Straten P; Svane IM
    Cancer Res; 2015 Sep; 75(18):3747-59. PubMed ID: 26183926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.
    Kriegsman BA; Vangala P; Chen BJ; Meraner P; Brass AL; Garber M; Rock KL
    J Immunol; 2019 Oct; 203(7):1999-2010. PubMed ID: 31471524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
    Matsuzaki J; Tsuji T; Luescher IF; Shiku H; Mineno J; Okamoto S; Old LJ; Shrikant P; Gnjatic S; Odunsi K
    Sci Rep; 2015 Oct; 5():14896. PubMed ID: 26447332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis.
    Boucherma R; Kridane-Miledi H; Vives FL; Vauchy C; Borg C; Kleinclauss F; Fiette L; Tiberghien P; Lemonnier FA; Rohrlich PS; Huetz F
    Eur J Immunol; 2012 Apr; 42(4):851-62. PubMed ID: 22531912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells.
    Seo MJ; Kim GR; Son YM; Yang DC; Chu H; Min TS; Jung ID; Park YM; Han SH; Yun CH
    Mol Immunol; 2011 Sep; 48(15-16):1744-52. PubMed ID: 21632112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte gene expression signatures from patients and mouse models of hereditary hemochromatosis reveal a function of HFE as a negative regulator of CD8+ T-lymphocyte activation and differentiation in vivo.
    Costa M; Cruz E; Oliveira S; Benes V; Ivacevic T; Silva MJ; Vieira I; Dias F; Fonseca S; Gonçalves M; Lima M; Leitão C; Muckenthaler MU; Pinto J; Porto G
    PLoS One; 2015; 10(4):e0124246. PubMed ID: 25880808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
    Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of cryopreserved peripheral blood mononuclear cells through a resting process for clinical immunomonitoring--Development of an algorithm.
    Wang L; Hückelhoven A; Hong J; Jin N; Mani J; Chen BA; Schmitt M; Schmitt A
    Cytometry A; 2016 Mar; 89(3):246-58. PubMed ID: 26848928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells.
    Adams PW; Lee HS; Waldman WJ; Sedmak DD; Morgan CJ; Ward JS; Orosz CG
    J Immunol; 1992 Jun; 148(12):3753-60. PubMed ID: 1351087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.
    de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R
    Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
    Doukas J; Pober JS
    J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer.
    Hellstrom I; Ledbetter JA; Scholler N; Yang Y; Ye Z; Goodman G; Pullman J; Hayden-Ledbetter M; Hellstrom KE
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6783-8. PubMed ID: 11371607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha, not CD154 (CD40L), plays a major role in SEB-dependent, CD4(+) T cell-induced endothelial cell activation in vitro.
    Baum D; Yaron R; Yellin MJ
    Cell Immunol; 1998 Nov; 190(1):12-22. PubMed ID: 9826442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.